(Q40897652)

24 September 2017

title

No effect of carvedilol on nitric oxide generation in phagocytes but modulation of production of superoxide ions (English)

1 reference

24 September 2017

1 reference

5

J Palmblad

1 reference

24 September 2017

S Asbrink

1

1 reference

24 September 2017

A Zickert

series ordinal

2

1 reference

24 September 2017

J Bratt

series ordinal

3

1 reference

24 September 2017

H Gyllenhammar

series ordinal

4

1 reference

24 September 2017

language of work or name

English

0 references

publication date

1 April 2000

1 reference

24 September 2017

published in

Biochemical Pharmacology

1 reference

24 September 2017

volume

59

1 reference

24 September 2017

issue

8

1 reference

24 September 2017

page(s)

1007-1013

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900393-7

24 September 2017

1 reference

Protective effects of carvedilol in the myocardium

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900393-7

Pharmacology of carvedilol: rationale for use in hypertension, coronary artery disease, and congestive heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900393-7

The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. U.S. Carvedilol Heart Failure Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900393-7

Safety and efficacy of carvedilol in severe heart failure. The U.S. Carvedilol Heart Failure Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900393-7

Carvedilol, a new beta-adrenoceptor antagonist and vasodilator antihypertensive drug, inhibits superoxide release from human neutrophils

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900393-7

Carvedilol, a new antihypertensive, prevents oxidation of human low density lipoprotein by macrophages and copper

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900393-7

Carvedilol, a new vasodilating beta adrenoceptor blocker antihypertensive drug, protects endothelial cells from damage initiated by xanthine-xanthine oxidase and neutrophils

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900393-7

Carvedilol, a new beta-adrenoreceptor blocker antihypertensive drug, protects against free-radical-induced endothelial dysfunction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900393-7

Stimulus-dependent transduction mechanisms for nitric oxide release in human polymorphonuclear neutrophil leukocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900393-7

The role of nitric oxide in lipoxin A4-induced polymorphonuclear neutrophil-dependent cytotoxicity to human vascular endothelium in vitro

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900393-7

Lipoxin A4 induces neutrophil-dependent cytotoxicity for human endothelial cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900393-7

Inhibition of neutrophil-dependent cytotoxicity for human endothelial cells by antirheumatic drugs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900393-7

Hydrogen peroxide and superoxide modulate leukocyte adhesion molecule expression and leukocyte endothelial adhesion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900393-7

Effects of nitric oxide on chemotaxis and endotoxin-induced interleukin-8 production in human neutrophils

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900393-7

Modulation of neutrophil migration by exogenous gaseous nitric oxide.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900393-7

Development and characterization of essential fatty acid deficiency in human endothelial cells in culture

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900393-7

Mechanisms for luminol-augmented chemiluminescence from neutrophils induced by leukotriene B4 and N-formyl-methionyl-leucyl-phenylalanine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900393-7

Measurement of methemoglobin formation from oxyhemoglobin. A real-time, continuous assay of nitric oxide release by human polymorphonuclear leukocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900393-7

Nitric oxide (NO) formation from nitrovasodilators occurs independently of hemoglobin or non-heme iron

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900393-7

Analysis of nitrate, nitrite, and [15N]nitrate in biological fluids

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900393-7

Carvedilol prevents low-density lipoprotein (LDL)-enhanced monocyte adhesion to endothelial cells by inhibition of LDL oxidation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900393-7

10.1016/S0006-2952(99)00393-7

7 January 2021

Identifiers

DOI

1 reference

24 September 2017

1 reference